Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 32Lymphoid 21Myeloid 16Plasma cell 9Sarcoma 4Genitourinary 4Classical hematology 3CNS 3Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1Lymphoma 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bone Marrow Transplantation × Dermatologic × Clear all
NCT00506129 2020-12-29

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
33 enrolled 4 charts
DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡